Similar articles for PMID: 20925545

Year	Number of Results
1989	1
1993	2
1995	1
1996	1
1999	1
2000	3
2001	2
2002	9
2003	5
2004	6
2005	1
2006	3
2007	4
2008	2
2009	1
2010	4
2011	3
2012	4
2013	2
2014	1
2015	5
2016	4
2017	6
2018	8
2019	3
2020	1
2021	4
2022	2
2024	0

1

Dystrophin immunity in Duchenne's muscular dystrophy.

Mendell JR, Campbell K, Rodino-Klapac L, Sahenk Z, Shilling C, Lewis S, Bowles D, Gray S, Li C, Galloway G, Malik V, Coley B, Clark KR, Li J, Xiao X, Samulski J, McPhee SW, Samulski RJ, Walker CM. Mendell JR, et al. N Engl J Med. 2010 Oct 7;363(15):1429-37. doi: 10.1056/NEJMoa1000228. N Engl J Med. 2010. PMID: 20925545 Free PMC article. Clinical Trial.

2

Autoimmunity in a genetic disease—a cautionary tale.

Moore MJ, Flotte TR. Moore MJ, et al. N Engl J Med. 2010 Oct 7;363(15):1473-5. doi: 10.1056/NEJMe1009056. N Engl J Med. 2010. PMID: 20925551 No abstract available.

3

Engineered DNA plasmid reduces immunity to dystrophin while improving muscle force in a model of gene therapy of Duchenne dystrophy.

Ho PP, Lahey LJ, Mourkioti F, Kraft PE, Filareto A, Brandt M, Magnusson KEG, Finn EE, Chamberlain JS, Robinson WH, Blau HM, Steinman L. Ho PP, et al. Proc Natl Acad Sci U S A. 2018 Sep 25;115(39):E9182-E9191. doi: 10.1073/pnas.1808648115. Epub 2018 Sep 4. Proc Natl Acad Sci U S A. 2018. PMID: 30181272 Free PMC article.

4

Anti-dystrophin T cell responses in Duchenne muscular dystrophy: prevalence and a glucocorticoid treatment effect.

Flanigan KM, Campbell K, Viollet L, Wang W, Gomez AM, Walker CM, Mendell JR. Flanigan KM, et al. Hum Gene Ther. 2013 Sep;24(9):797-806. doi: 10.1089/hum.2013.092. Hum Gene Ther. 2013. PMID: 24010700 Free PMC article.

5

Immune response to full-length dystrophin delivered to Dmd muscle by a high-capacity adenoviral vector.

Gilchrist SC, Ontell MP, Kochanek S, Clemens PR. Gilchrist SC, et al. Mol Ther. 2002 Sep;6(3):359-68. doi: 10.1006/mthe.2002.0675. Mol Ther. 2002. PMID: 12231172 Free article.

6

Gene therapy for Duchenne muscular dystrophy: AAV leads the way.

Judge LM, Chamberlain JS. Judge LM, et al. Acta Myol. 2005 Dec;24(3):184-93. Acta Myol. 2005. PMID: 16629052 Review.

7

Dystrophin delivery in dystrophin-deficient DMDmdx skeletal muscle by isogenic muscle-derived stem cell transplantation.

Ikezawa M, Cao B, Qu Z, Peng H, Xiao X, Pruchnic R, Kimura S, Miike T, Huard J. Ikezawa M, et al. Hum Gene Ther. 2003 Nov 1;14(16):1535-46. doi: 10.1089/104303403322495043. Hum Gene Ther. 2003. PMID: 14577915

8

Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy: A Nonrandomized Controlled Trial.

Mendell JR, Sahenk Z, Lehman K, Nease C, Lowes LP, Miller NF, Iammarino MA, Alfano LN, Nicholl A, Al-Zaidy S, Lewis S, Church K, Shell R, Cripe LH, Potter RA, Griffin DA, Pozsgai E, Dugar A, Hogan M, Rodino-Klapac LR. Mendell JR, et al. JAMA Neurol. 2020 Sep 1;77(9):1122-1131. doi: 10.1001/jamaneurol.2020.1484. JAMA Neurol. 2020. PMID: 32539076 Free PMC article. Clinical Trial.

9

Identification of an HLA-A*0201-restricted epitopic peptide from human dystrophin: application in duchenne muscular dystrophy gene therapy.

Ginhoux F, Doucet C, Leboeuf M, Lemonnier FA, Danos O, Davoust J, Firat H. Ginhoux F, et al. Mol Ther. 2003 Aug;8(2):274-83. doi: 10.1016/s1525-0016(03)00179-5. Mol Ther. 2003. PMID: 12907150 Free article.

10

A simplified immune suppression scheme leads to persistent micro-dystrophin expression in Duchenne muscular dystrophy dogs.

Shin JH, Yue Y, Srivastava A, Smith B, Lai Y, Duan D. Shin JH, et al. Hum Gene Ther. 2012 Feb;23(2):202-9. doi: 10.1089/hum.2011.147. Epub 2011 Dec 14. Hum Gene Ther. 2012. PMID: 21967249 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

84 results

Results by year